Â鶹ÊÓƵ

An Aboriginal epidemiologist and a leading gynaecologic oncologist have been elected as Fellows of the Australian Academy of Health and Medical Sciences (AAHMS).

, Director of Â鶹ÊÓƵ of Queensland’s and  from Â鶹ÊÓƵ’s  (Â鶹ÊÓƵCCR) are recognised for their significant and continuing contributions to health and medical sciences.

Professor Ward has also been awarded the inaugural AAHMS medal for Outstanding First Nations Researcher.
 

Improving Aboriginal and Torres Strait Islander health and wellbeing

Professor James Ward, a Pitjantjatjara and Narungga man, has led large scale research studies over the last 20 years aimed at improving the health and wellbeing of Aboriginal and Torres Strait Islander peoples across Australia.

His work has specialised in infectious diseases, particularly sexual health, HIV and viral hepatitis.

More recently he has developed an urban Aboriginal and Torres Strait Islander research program, also leading to significant research studies.

“Science is an exciting area to work in and I really thrive on discovery and being able to answer complex questions that many before me haven’t been able to solve,” Professor Ward said.

“Each bit of research builds on the last bit.

“Even if we don’t hit that end goal, we are moving towards liberation from inequity.”

Professor Ward said he shares the Outstanding First Nations Researcher Medal with those he has collaborated with, as well as the communities he has been fortunate to work with over the years.

“I’m standing on the shoulders of giants, my own peoples who have paved the way for our people, some of whom have been fighting a good fight for decades and some who have passed on,” he said.

“Hopefully I’m doing those people proud and those next generations coming through.”
 

Leading the way to better outcomes for gynaecological cancer patients

Professor Andreas Obermair is a gynaecologic oncologist, surgical teacher, researcher and consumer advocate.

His research influences clinical management of patients with cervical, ovarian, endometrial and vulval/vaginal cancer.

Professor Obermair said being elected by his peers to be an AAHMS Fellow was an honour.

“I am incredibly humbled to receive this Fellowship, which I dedicate to the thousands of women across Australia who are diagnosed with gynaecological cancer each year,” Professor Obermair said.

“Over the past 21 years, my work has focused on providing patient care and conducting clinical research to improve outcomes.

“Our efforts aim to develop treatments that are not only more effective but also minimise harm to patients.”

Professor Obermair said his work at the was focused on translating scientific knowledge into clinical practice, and identifying areas where current treatments are ineffective or unnecessarily harmful.

“Our research aims to deliver tangible benefits by informing and improving clinical care and providing better options for patients and their families,” he said.

“Despite progress, gynaecological cancer research faces ongoing challenges, particularly around limited funding and the stigma associated with these cancers – addressing these issues requires continued focus and effort.

“We remain committed to advancing research and improving outcomes for women affected by gynaecological cancer.”

The new Fellows were welcomed in a ceremony at the AAHMS annual meeting in Adelaide.

Image above left: Professor Andreas Obermair.

Media contact

Â鶹ÊÓƵ Communications
communications@uq.edu.au
+61 429 056 139